This Week In HRV - Episode 32

[00:00:00] Welcome back friends, to the Heart Rate Variability Podcast. This week in Heart Rate Variability Edition. Each week we do what we always do. We go into the research, pull out what is new, what is meaningful, what is uncertain, and we try to make sense of it together, clearly, rigorously and without the hype that tends to travel faster than the science. Please consider everything in this podcast for informational purposes only and not as medical advice. Always consult your qualified healthcare provider, please, before applying any strategies, protocols or frameworks we discuss here. This week we have nine new studies to explore and I want to say right from the start, this is an episode that spans an unusual breadth of terrain. We are going to travel from the psychophysiology laboratory where researchers put HRV biofeedback head to head against a genuine placebo condition to the mathematics of chaos theory and what nonlinear fluctuations in your heartbeat might be telling us about the activity of your thinking mind. We are going to spend time in the world of sport related concussion asking a question that may surprise you. What does nocturnal heart rate variability reveal about an athlete who is clinically recovered but whose body hasn't quite finished the job? We will look at two studies from the acute and emergency cardiac care setting, one examining how changes in short term HRV over the weeks after a heart attack predict who survives and who doesn't, and another piloting a decision support tool that asks whether HRV can help emergency physicians identify which infection patients are about to deteriorate. [00:01:17] Then we'll turn to the beautifully abstract world of point shape plot geometry and ask what shapes on a scatter plot reveal about human autonomic function that conventional HRV metrics do not. We'll check in with runners, a community adopting HRV monitoring at a striking rate, and ask the harder question of whether they are actually using what they measure. We will visit a randomized controlled trial that used music listening as an intervention in chronic pain patients and found an unexpected autonomic signal in the data. And we will close with a study that sits at a genuinely underexplored the autonomic nervous system science, sleep disturbance and the gut brain axis in children. Nine studies, a wide field and as always, a commitment to carrying both the finding and the uncertainty together through the whole conversation before we begin the same grounding word we offer every week. The research we discuss spans exploratory cross sectional designs, small sample sizes, observational frameworks and preliminary clinical pilots. In cross sectional studies we are seeing associations, not causes. Where sample sizes are small, statistical power is limited and generalizability is constrained. The caveats in this podcast are not disclaimers buried at the end they're part of the scientific story woven into every section. Because responsible engagement with early stage research requires holding the result and the uncertainty simultaneously. That discipline is what separates genuine scientific literacy from simply collecting impressive sounding findings. With that framing on the table, let's begin. There is a question that sits at the heart of any serious evaluation of HRV biofeedback as a clinical intervention and and it has been surprisingly difficult to answer with methodological rigor. Is the benefit of HRV biofeedback real or is it substantially a placebo effect when people feel calmer, less depressed and less distressed after weeks of slow resonance frequency breathing with visual feedback? Is that because the intervention did something specific to the autonomic nervous system or because they believed it would help, were given attention, were engaged in a structured daily practice, and were enrolled in a study where someone cared about their well being? These mechanisms are not trivial. To separate and separating them requires something that most HRV biofeedback research has a genuine convincing sham condition. This study was published in Biological Psychology and is titled Psychophysiological Effects of heart rate biofeedback vs sham biofeedback a Randomized Controlled Trial. The authors are Sephora Minjose, Rudy Jean, Sonia Pelissier and Pascal Haut. The design here is carefully constructed. 47 healthy adults participated. All of them underwent three comprehensive assessments spaced 24 days apart. Those assessments captured two categories of information simultaneously. The first was psychological affectivity, both positive and negative anxiety, depression, perceived stress, coping strategies and life satisfaction. The second was physiological autonomic nervous system activity measured through HRV and electrodermal activity assessed across three at rest, during reactivity to an overload cognitive task and and in recovery from that task. This three phase protocol rest stress recovery is methodologically important because it tests whether HRV biofeedback changes not just your resting baseline but your capacity to respond to challenge and return to equilibrium. That is the clinical question that matters Most. After a 24 day pre training period, which establishes an important baseline and controls for time effects, participants were randomly assigned to one of two conditions. The HR of I biofeedback group, consisting of 24 participants with a mean age of 35, received genuine resonance frequency breathing with real time visual feedback of their heart rate variability. They practiced for five minutes three times a day. Over the 24 day training period, the Sham HRV Biofeedback Group, 23 participants with a mean age of 28 received a convincing placebo. They went through the same structure, the same daily practice cadence, the same visual interface, but the feedback they received was not actually tied to their real physiological signal. So they were doing something that looked and felt like HRV biofeedback but didn't actually engage the autonomic feedback loop. Now here's what the data showed, and it contains both a strong positive result and a deeply interesting complication on the psychological outcomes. The HRV biofeedback group clearly outperformed the sham group. Positive effectivity improved significantly in the genuine biofeedback condition compared with the sham condition. Depression was meaningfully reduced. These are not trivial psychological changes, and they were produced by a 24 day protocol of five minutes three times a day, a modest practical burden. The fact that these improvements exceeded those in the sham condition is important. It means the benefits of genuine HRV biofeedback are not entirely explained by placebo mechanisms, expectation, or the general effects of structured daily practice. Something about the real intervention, something specific about genuinely and training the autonomic system through resonance frequency, breathing and accurate feedback is producing psychological benefit above and beyond belief and ritual. But here is where the study becomes more complex. On the physiological side, HRV itself there were no significant differences between the genuine and sham conditions, neither at rest, nor in reactivity of the cognitive stress task, nor in recovery from it. The autonomic system as measured did not differentiate between the groups. The psychological benefits of genuine HRV biofeedback were not accompanied by detectable changes in HRV itself, and the exploratory analyses deepened this puzzle further. When the team examined whether higher respiratory mediated HRV during practice, meaning a larger HRV amplitude during the actual biofeedback session predicted better psychological outcomes, the answer was no. A bigger HRV response during practice did not reliably correspond to greater psychological benefit. The physiological magnitude of engagement and the psychological benefit came apart. What do we make of this? The authors discuss it with appropriate nuance, and it is worth sitting with carefully rather than rushing to a clean interpretation. One possibility is that HRV as measured in 5 minute resting and task conditions is not the mechanism through which the psychological benefits of HRV biofeedback operate. The intervention may be working through pathways that HRV indices in the measurement windows use cannot capture. Perhaps central nervous system adaptation, shifts in interoceptive processing, changes in breathing pattern regulation that persist outside formal practice sessions, or some combination of these. Another possibility is that the measurement windows and indices employed were not sensitive enough to detect the autonomic changes that did occur. The methodological constraints deserve careful articulation. The sample is 47 healthy adults, not a clinical population with anxiety disorders, depression, diagnoses, or or establish autonomic dysfunction. Which are the populations where HRV biofeedback is most often deployed. Clinically, the mean age difference between groups 35 versus 28 introduces a potential confound. Since autonomic function varies with age, the Training period was 24 days. Longer protocols might produce stronger psychological effects and detectable physiological changes that this study cannot address. The sex distribution is notable. Both groups contained only five male participants, making the sample heavily female weighted while, which may influence both HRV baseline values and psychological outcome trajectories. Despite these constraints, the contribution here is genuinely important. This is among the more rigorously controlled randomized comparisons of HRV biofeedback against a valid sham condition in the published literature. The finding that psychological benefits exceed placebo even without detectable HRV changes does not undermine HRV biofeedback. It asks us to be more precise about what we think it is doing and why. For clinicians recommending this intervention to patients managing stress, low mood, or emotional dysregulation, the evidence base just got cleaner. The benefits appear to be real. The mechanism may be more subtle than the phrase it improves your HRV implies, and that is a conversation worth having openly with patients rather than papering over. If the previous study asked whether HRV biofeedback benefits are specific and real, this next study asks something more fundamental still. Are we even looking at the right features of the HRV signal when we measure time domain and frequency domain and indices during cognitive work? Because there is a growing body of evidence suggesting that when the mind is engaged, when the brain is actively processing problem solving, maintaining working memory, the most meaningful changes in the heart rate signal may not show up in RMSSD or LF HF ratio at all. They may show up in the nonlinear dimension of hrv, the degree to which the interval sequence is chaotic, complex, and irregular in ways that conventional indices are architecturally incapable of detecting. [00:09:02] The study was published in Scientific Reports titled Chaotic fluctuations mark the sign of Mental activity and Task Based Heart Rate Variability. The authors are Tomoyuki Mao, Hidetoshi Okutomi, and Ken Umeno. The central premise of this work is worth grounding carefully because it requires a small but meaningful conceptual shift from how most people think about hrv. The conventional framework treats healthy HRV as higher is better but more variability, more parasympathetic tone, greater adaptive flexibility in both the time domain and the frequency domain. That framework holds reasonably well for resting conditions, but the human cardiovascular system is not a linear system, it is intrinsically nonlinear. The sequence of RR intervals your heart produces is not simply fluctuating randomly around a mean, nor is it organized in clean sinusoidal oscillations. It contains a structure that emerges from the complex non additive interaction of multiple regulatory systems operating simultaneously across different timescales. Chaos theory and complexity science offer mathematical tools specifically designed to detect that kind of structure, and they produce indices that conventional linear methods cannot replicate. What Mao, Okitomi and Umeno did was conduct a comprehensive comparison across all three analytical frameworks simultaneously time domain, frequency domain and chaos and complexity indices derived from RR interval analysis during both physical and mental tasks. The key comparison is between those two task physical tasks which load the cardiovascular system in ways we are physiologically accustomed to modeling, and mental tasks with sustained cognitive work, which load the brain without demanding the same cardiovascular output changes. The results are striking in their clarity. During mental tasks, conventional time domain and frequency domain HRV indices showed no significant changes relative to rest RMSSD did not move. LF power did not move HF power did not move. [00:10:47] By the standard metrics, the cognitive tasks left the HRV signal looking essentially unchanged. But chaos and complexity indices told a different story entirely. During mental tasks, chaos and complexity indices increased significantly. The heart rate signal became measurably more chaotic, more dynamically complex, less predictable in its beat to beat structure when the brain was actively engaged in cognitive work. The authors propose a new hypothesis consistent with prior theoretical frameworks about why cognitive activity produces this specific signature. The reasoning is physiologically coherent mental tasks engage prefrontal and limbic networks that modulate autonomic outflow via pathways not captured in the frequency profiles of vagal and sympathetic oscillations. These pathways introduce a form of central nervous system driven nonlinear variability into the cardiac signal. The brain in essence imposes its complex dynamics on the heart, and those dynamics are visible in chaos indices, not in RMSSD or spectral power. The implications extend across virtually every domain of HRV research and application. If you are measuring HRV during or after cognitive load during sustained attention tasks, during learning, during problem solving, during decision making, under pressure, and you are using only conventional linear metrics, you may be looking at the wrong part of the signal. The brain heart connection during mental work appears to manifest in a dimension of the HRV signal that most devices, apps, and research protocols are not designed to detect or report. [00:12:04] The methodological constraints are worth naming precisely. The specific cognitive and physical tasks employed require examination of the full paper to evaluate ecological validity, whether the findings hold for naturalistic mental work rather than laboratory paradigms. The specific nonlinear indices employed and the analytical choices that govern them vary considerably across the complexity science literature, and replication with different indices and methods is essential before these findings become a clinical or applied standard. And the study, while clearly articulated in its central finding, raises more questions than it answers. Does chronic cognitive load produce sustained shifts and chaos indices? Do high cognitive demand professions show different baseline complexity profiles? Does HRV complexity training interact with cognitive performance the way HRV amplitude training does? Let's move now from the cognitive neuroscience of the heartbeat into the high stakes world of athletic injury, specifically sport related concussion. This is a domain where HRV research has been gaining genuine clinical traction over the past decade, but most of that work is focused on the acute phase following head injury. This next study asks a different, clinically more challenging question. What happens to the autonomic system in athletes who appear to have recovered, whose clinical symptoms have resolved but who take longer than expected to return to sport? Is the nervous system truly recovered or is nocturnal HRV telling a different story than the symptom checklist? This study was published in Scientific Reports and is titled Nocturnal Autonomic activity in athletes with Regular versus Prolonged Return to sport after Sport Related Concussion. The authors are Ann Karina Dellingbrandt, Rasmus Jakobsmeyer, Jessica Koenen and Claes Reinsberger. The design is explicitly exploratory and cross sectional. The authors are transparent about this and these qualifications are important to carry through the entire discussion. The study enrolled 17 athletes with sport related concussion and 17 match control athletes without concussion. The concussion group was then further divided based on their individual return to sport timelines, 10 athletes with a regular return to sport fewer than 28 days and seven athletes with a prolonged return to sport 28 days or more. Nocturnal autonomic activity was measured using a multimodal wearable device across two windows directly during the return to sport period itself and post return to sport, meaning more than three weeks after the athlete had been cleared to resume full competition. The key autonomic outcomes were heart rate, rmssd, the primary index of beat to beat, parasympathetic variability, and electrodermal activity, which captures phasic sympathetic activity through sweat gland responses during sleep. Here's what the data showed during the return to sport period when all athletes were still actively recovering and navigating graduated exertion protocols. No significant differences in concussion symptoms, heart rate, rmssd, or electrodermal activity were found between the regular and prolonged recovery groups. The autonomic signal during active recovery did not differentiate the two groups across any of the measured parameters, but after return to sport, after the athletes had been cleared, after their clinically assessed symptoms had resolved, after the formal recovery process was declared complete, a significant separation emerged. Prolonged return to sport athletes showed significantly lower than nocturnal RMSSD compared to both regular return to sport athletes and uninjured controls. The effect size was Notable, r equals 0.612. Additionally, prolonged return to sport athletes exhibited fewer phasic electrodermal activity events during sleep, what the authors call sleep storms compared to regular return to sport athletes. There's something quietly important about the timing of this finding. The autonomic difference did not appear during recovery and it appeared after clinical clearance. When sports medicine physicians, physiotherapists, and coaches declared the athlete ready to compete, the autonomic nervous system had not yet returned to the profile seen in athletes with uncomplicated recoveries, the RMSSD was lower and the phasic sympathetic activity during sleep was reduced, together suggesting a nocturnal autonomic state characterized by diminished dynamic activity across both the parasympathetic and sympathetic dimensions. The authors carefully offer two interpretive hypotheses. One is insufficient physiological recovery. The brain and the autonomic regulatory networks embedded within it have not fully restored their pre injury function despite the resolution of reportable symptoms. Concussion affects brainstem and prefrontal structures that contribute to autonomic modulation, and subclinical dysfunction in those networks may persist beyond the point where questionnaires and clinical examination reveal anything abnormal. The other hypothesis is deconditioning prolonged recovery. Athletes were sidelined for longer and engaged in less physical training and may exhibit autonomic profiles reflecting reduced cardiovascular fitness rather than ongoing neurological injury. The data cannot adjudicate between these two possibilities and they may not be mutually exclusive. The methodological limitations are significant. The sample sizes are very small seven athletes in the prolonged recovery group and the statistical power this affords is limited. The match control design is a strength, but 17 concussion athletes in total is a starting point for hypothesis generation, not a foundation for clinical guidelines. The 28 day classification threshold for prolonged versus regular recovery is a practical construct, not a biologically validated cutoff, and the cross sectional snapshot design cannot tell us whether the post clearance RMSSD suppression resolves over subsequent months or persists as a lasting autonomic marker of incomplete recovery for sports medicine clinicians, team physicians, and neurology professionals who work with concussion patients. The practical implication is not to delay return to sport until RMSSD normalizes. The evidence does not support that protocol, and this sample is far too small to inform such a recommendation. The implication is more preliminary but still important. Nocturnal HRV monitoring in concussion athletes may provide information about autonomic recovery status that clinical symptom assessment does not capture. This study opens that door, and it is a door worth walking through in the next generation of research. We move now from the sports field to the hospital ward and specifically to one of the highest stakes clinical settings in all of medicine and the acute aftermath of a heart attack. Heart rate variability has a long history in post myocardial infarction risk stratification, stretching back to foundational work in the 1990s which established that depressed HRV after acute coronary syndrome is a powerful predictor of mortality, but that early literature relied Almost entirely on 24 hour Holter recordings taken in the early post infarct period. A more clinically actionable question, one that could change how we use HRV at the bedside rather than just as a research variable, is whether short term HRV measured in 5 minute resting ECG windows, can track meaningful changes in autonomic function over time after a heart attack and whether those changes predict who lives and who doesn't. This study was published in Diagnostics and is titled Short Term Heart Rate Variability Dynamics and Mortality Risk after Acute Coronary Syndrome. The authors are Nicola Markovich, Masha Petrovic, Sylvana Babic, Mila Vanboj and Branislav Milovanovic, all from the Institute for Cardiovascular Diseases, Dedinye in Belgrade, Serbia. This is a retrospective prospective study combining historical data with prospectively collected follow up information, enrolling 230 patients with acute myocardial infarction that is a meaningful sample size for this domain. The protocol was clinically practical. Five minute resting ECG recordings were obtained on two day one of hospitalization and day 21. From these recordings, standard time domain and frequency domain HRV parameters were extracted. Crucially, the team also calculated delta values, the change in each HRV parameter from day one to day 21, which allowed them to examine not just the level of HRV at either time point, but the trajectory was the autonomic system recovering, staying flat or continuing to deteriorate across the first three weeks after the infarct. The primary endpoint was overall mortality during follow up. Here's what the analysis revealed. Patients who died during follow up had lower HRV values on day 21 compared to survivors, consistent with the long standing literature. But the more novel and clinically interesting finding involves the delta values. Patients who died showed more pronounced declines in selective parameters across the day 1 to day 21 window in the multivariable Cox regression analysis, which controls for multiple potential confounders simultaneously. Two variables emerged as independent predictors of overall mortality. First, decreased delta lf, meaning a decline in low frequency spectral power from day one to day 21. Second, shorter RR intervals at day 21, meaning a higher average heart rate. Patients whose LF power fell across the three week window z and whose heart rate remained elevated rather than recovering toward a lower, more parasympathetically modulated baseline were at significantly higher risk of death during follow up. A declining LF over three weeks rather than stabilizing or recovering likely reflects persistent autonomic imbalance, a nervous system that is not re establishing its regulatory capacity as the heart heals. The myocardium itself may be structurally recovering from the infarct, but the autonomic networks that modulate cardiac function may follow a different, slower and in some patients, incomplete recovery trajectory. The practical bedside implication is direct. [00:20:20] A five minute resting ECG is neither a demanding nor a costly clinical procedure. It is available in virtually every hospital setting without specialized equipment. If tracking HRV parameters from two such recordings, one at admission, one at three weeks can provide independent prognostic information beyond standard clinical variables that would be a meaningfully accessible tool for post infarct risk stratification. The question is whether these findings hold in larger, more contemporary cohorts with modern revascularization practices, which the authors explicitly acknowledge in their call for further study. The methodological constraints are real, the retrospective perspective hybrid design carries the limitations of retrospective data, incomplete standardization of recording conditions, and potential selection bias in who has available recordings. The study population is from a single institution and the sample, while larger than many HRV studies, still represents a single national context with its specific patient demographics, clinical practices, and disease severity distributions. What this study adds to the HRV after ACS literature is the temporal dynamics framing it is not enough to know HRV at a single moment the direction of change. Is the autonomic system recovering its variability, or is it continuing to contract? Carries a prognostic signal that a single point measurement cannot provide? That reframe has direct clinical and research design implications. Future post infarct HRV studies should treat trajectory, not just level, as the primary variable of interest. One of the most practically urgent questions in emergency medicine is a prediction problem. When a patient arrives in the emergency department with signs and symptoms of infection, some will remain stable and go home. Others will deteriorate rapidly, requiring intensive care, vasopressor support, mechanical ventilation, or worse. The clinical tools currently used to identify which patients are on which trajectory established severity scores, lactate vital sign patterns are imperfect, Emergency physicians are making high stakes decisions under time pressure with incomplete prognostic information and patients who could benefit from early escalation of care are sometimes not identified until they are already in crisis. This study was published in Biomed Research International titled A Heart rate variability derived decision support tool for prognostication in emergency department patients with suspected Infection. The Authors are Andrew J.E. seeley, Douglas P. Barnaby, Natasha Hudek, Christophe L. Harry, Nathan B. Scales, Shannon M. Fernando, Jamie C. Brayhoutt and Jeffrey J. Perry. This study was a Phase 1 feasibility implementation study and that framing matters. The team was not asking in this paper whether the tool predicts outcomes better than current clinical tools. They were asking a prior question can we actually deploy an HRV based clinical decision support tool in a real emergency department with real patients, real clinicians and real time constraints and have IT function? And what did the clinicians who use it think of it? The tool evaluated is called Sepsis Advisor. It combines 30 minutes of electrocardiographic recording capturing HRV across a clinically meaningful window with laboratory values including creatinine, lactate and INR to generate a predictive model of future deterioration risk. [00:23:07] The study enrolled 71 patients, all with suspected or treated infection and evidence of systemic inflammatory response 65. Of those 71, 92% had adequate duration of HRV measurements to generate a predictive model with an average recording of 25 minutes that is a critical feasibility metric in the chaotic environment of an emergency department. A 30 minute ECG recording completed successfully 92% of the time represents a viable clinical workflow. The generated Sepsis Advisor reports were shown to physicians observationally, importantly more than 48 hours after the clinical encounter so they could not influence care decisions in this pilot phase. The research team then assessed perceived usability value and implementation barriers through structured interviews with nurses and physicians. What clinicians and nurses said about the tool is worth conveying in some detail. The reported drivers for adoption included the tool's potential to facilitate communication between team members about deterioration risk, improved the quality and timing of care decisions, and its perceived ease of integration into existing clinical documentation workflows. Those are meaningful signals. Clinicians were not dismissing the concept they could see how it would fit into their workflow. The barriers, however, were equally candid and important. [00:24:15] Clinicians identified the need to understand and correctly interpret the HRV based output as a real friction point, not because the display was confusing per se, but because HRV as a physiological concept is not part of standard emergency medicine training and a score derived from it requires a layer of interpretive trust that has to be built. Time constraints in the emergency department were named explicitly changing established clinical routines even for a potentially valuable tool is difficult in high pressure environments, and gaining organizational and peer buy in for a novel monitoring modality requires a body of evidence that a phase one feasibility study by design is not yet providing user centered feedback from the interviews inform four iterations of the Sepsis Advisor interface over the study period. That responsiveness to real world clinical feedback is exactly the kind of development process that separates a research prototype from a clinically deployable product. The methodological constraints here are fundamental to the study's own stated scope. This is a 71 patient pilot at two sites within a single academic health sciences center. There's no control arm. The tool's predictive accuracy is not the subject of this paper. That question requires a larger, adequately powered clinical trial. These are all things the study explicitly does not claim to answer, and that clarity about scope is itself a methodological virtue. This study demonstrates that HRV based clinical decision support for infection related deterioration in in the emergency department is feasible to deploy, practical to administer, and perceived by real clinicians as having genuine potential value. The clinical stakes for better early deterioration prediction in sepsis are enormous. Globally, sepsis mortality remains catastrophically high and early identification remains the most powerful ever available. The technical framework Seely and colleagues have piloted, if validated in an adequately powered efficacy trial, could represent a meaningful contribution to that problem. Before we continue into the second half of today's episode, let's pause for a word from our sponsor. This episode is brought to you by Optimal hrv, the platform built from the ground up for people who take heart rate variability seriously. One thing I want to highlight today is the trend analysis feature, which does exactly what the study we just discussed points toward. It doesn't just show you today's HRV number. It tracks the direction and velocity of change in your HRV over time against your personal baseline. When your RMSSD declines week over week, even if today's number doesn't look alarming in isolation, OptimalHRV's trend view surfaces the signal clearly. [00:26:21] For clinicians, this is particularly valuable when tracking autonomic recovery in patients post procedure or post illness. For individuals, it reframes the daily reading from a snapshot into a chapter in a longer narrative. Whether you are a clinician looking for a rigorous monitoring tool, a researcher tracking participants over time, or someone genuinely trying to understand what your nervous system is doing, optimal HRV is worth your time. Head to optimalhrv.com to learn more. No medical claims, just serious evidence. Informed tracking designed for people who want more than a colored ring on an app. [00:26:48] Most of the heart rate variability research we discuss focuses on the familiar root mean square of successive differences, standard deviation of normal to normal R to R intervals, percentage of adjacent R to R intervals differing by more than 50 milliseconds, low frequency power, high frequency power and the low frequency to high frequency ratio. These are the workhorses of the field. But there is a category of heart rate variability analysis that sits in an interesting middle ground between conventional linear methods and the more abstract world of chaos and complexity indices, and that is nonlinear geometric analysis. Specifically the Poincare plot, a scatter diagram constructed by plotting each R to R interval against the one that immediately follows it. The shape of that scatter diagram and the mathematical parameters derived from it contain information about the structure of the interval sequence that time domain averages and frequency domain power spectra cannot fully represent. This study was published in Diagnostics 2026 and is titled Associations of point plot Derived parameters with Heart rate variability and Autonomic reflex testing in a real world Clinical Population. The authors are Branislav Milovanovic, Nikola Matthew Markovich, Masha Petrovich, Alexa Korogic and Milovan Bojic. The setting here is importantly different from most heart rate variability studies. This is not a healthy volunteer cohort or a sports science sample. This is a real world clinical population. 269 adult patients referred for evaluation of suspected autonomic dysfunction. These are people with clinical presentations that have prompted a physician to order formal autonomic testing. That clinical context gives this study considerable ecological validity because the population most likely to benefit from improved autonomic phenotyping using Poincheur a plot analysis exactly this group patients in whom standard autonomic assessment has not fully resolved the diagnostic picture. All 269 participants underwent three forms of assessment simultaneously short term resting electrocardiogram, five minute recordings for conventional heart rate variability parameter extraction cardiovascular autonomic reflex testing which includes standardized maneuvers like the Valsalva maneuver, heart rate response to deep breathing and heart rate response to standing, all designed to probe specific autonomic reflex ARCs and and 24 hour Holter electrocardiogram monitoring for long term heart rate variability parameter extraction. This multi method design allowed the team to examine point shrey plot parameters not just in isolation but in their relationships to both conventional short and long term heart rate variability indices and to the gold standard clinical autonomic assessment of reflex integrity. The Poincare plot parameters analyzed included six the vector length index, the vector angle index, Poincare length, Poincare dispersion, the long axis and the short axis. Without going into the full geometric derivation of each, which is available in the full paper. These parameters capture different aspects of the ellipsoidal shape of the scatter plot, including its size, elongation and the distribution of points within it. All parameters except the vector angle index are expressed in milliseconds. The vector angle index is expressed in degrees. Here's what the correlational analysis revealed. The vector length index and the long axis showed strong associations with long term heart rate variability indices, particularly with global and long term measures of autonomic variability, most notably the standard deviation of normal to normal R to R intervals and total spectral power. They appear to capture something about the broad slow dynamics of autonomic regulation over extended time windows. The vector angle index and the short axis, by contrast, were more closely associated with parasympathetic modulation indices, connecting them more tightly to the short window beat to beat regulation typically indexed by the root mean square of successive differences, the percentage of adjacent R to R intervals differing by more than 50 milliseconds, and high frequency power across all parameters. Associations with short term heart rate variability were generally weak. This is a meaningful pattern. Pointer 8 Plot geometry is capturing dimensions of autonomic regulation that are not well represented by five minute recording snapshots, even though those snapshots remain the most successful clinical measurement. The autonomic reflex testing results are clinically important. Patients with abnormal parasympathetic reflex test results, meaning their heart rate response to deep breathing and Valsalva maneuver responses with where outside normal reference ranges showed significantly lower values of selected points. Array plot parameters, specifically the vector length index and the vector angle index were lower in patients with an abnormal Valsalva maneuver result, while the vector angle index, the long axis and the short axis were lower in patients with an abnormal heart rate response to deep breathing. Those parameters distinguish people with documented parasympathetic reflex dysfunction from those without it. No significant differences were found in relation to orthostatic hypotension, the drop in blood pressure upon standing that serves as one of the principal clinical markers of sympathetic dysfunction, suggesting that the Penguier A plot parameters in this study's framework are more sensitive to parasympathetic than sympathetic reflex integrity. The practical implication for clinical autonomic assessment is Penguil plot analysis is not a redundant repackaging of information that the standard deviation of normal to normal R to R intervals or the root mean square of successive differences already provide. It captures complementary aspects of autonomic regulation, particularly the long term structural dynamics of the interval sequence that conventional indices underrepresent in a population of patients with suspected autonomic dysfunction. Adding point create plot parameters to the standard heart rate variability report may enhance the clinician's ability to characterize the specific nature of that dysfunction, its temporal scale, its predominant autonomic branch, and its relationship to reflex integrity. [00:31:38] The methodological constraints are clear. This is an observational correlational study. It cannot tell us whether Poincare plot analysis changes clinical decisions or or improves patient outcomes. The sample is from a single institution in Serbia, and the clinical referral pattern of that institution shapes who is in the data set. The statistical approach Spearman rank correlation with false discovery rate correction is appropriate and conservative, but the interpretation of specific correlation magnitudes as clinically meaningful requires validation in independent cohorts. The study also lacked a healthy control group, which limited the ability to define normative reference ranges for these parameters. And the 6.08 parameters analyzed here are not the only ones available in the literature. Different choices would have produced different patterns for the field as heart rate variability analysis moves toward richer, multi domain characterization of autonomic function, combining linear, nonlinear and geometric approaches. Studies like this one that rigorously map the relationships between method families and real clinical populations are exactly the foundational work needed to build a coherent, actionable autonomic assessment framework. Let's step out of the clinic entirely now and into the world of recreational sport. [00:32:42] Specifically, running is an activity pursued by hundreds of millions of people globally at every level, from weekend jogger to elite competitor. Running is also one of the communities where wearable HRV monitoring has penetrated most deeply. Devices are tracking HRV in runners, bedrooms, and on running trails worldwide, generating a volume of autonomic data that dwarfs anything the research literature has ever intentionally collected. And yet a surprisingly basic empirical question had not been asked of the runners who are actually monitoring hrv, how many are doing anything with the information? [00:33:10] This study was published in the Journal of Exercise and Nutrition and is titled the Prevalence of Heart Rate Variability Monitoring among a Sample of Habitual Runners. The authors are Andrew J. Karnes and Sarah E. Mahoney, both from the Department of Exercise Science at Bellarmine University in Louisville, Kentucky. The design is a survey study 210 habitual runners, defined as individuals aged 18 to 65 who reported running at least three days per week for at least six months and competing in at least two races annually. [00:33:38] These are not casual joggers these are consistent, engaged runners with enough investment in the activity to race regularly. Participants completed a 13 item survey on training habits and wearable device use. The primary outcome variables were the prevalence of HRV monitoring, the devices used, and crucially, whether runners reported adjusting their training based on their HRV readings. The findings are rich with both positive surprise and a significant gap on the adoption side. 47% of respondents, 99 out of 210 reported regularly monitoring HRV. That is nearly half of a habitual running sample, which is a striking market penetration for a physiological metric that 15 years ago was known almost exclusively to exercise scientists and cardiologists. The technology has democratized access to HRV in ways few anticipated. The device distribution was heavily dominated by Garmin, which accounted for 71% of HRV trackers, a reflection of the brand's dominance in the GPS running watch market and its integration of HRV based readiness features into its consumer platform. The sex finding is notable. Significantly more HRV users were male 57.6% than female, a statistically significant difference P 0.027. This gender gap in HRV monitoring adoption despite roughly equal representation in habitual running communities is worth investigating further. It may reflect differences in technology adoption, behavior differential marketing of wearable analytics platforms across sex demographics or differences in interest in physiological self monitoring. One finding that aligns with the competitive level is worth noting. HRV monitoring was equally prevalent among self described competitive and recreational runners. The chi square comparison was Non significant with P 0.49. This is interesting because it suggests that the adoption of HRV monitoring has moved beyond the serious competitive performer into the general recreational runner population and now the gap. Of the 99 runners who reported regularly monitoring HRV or only 20% reported adjusting their training based on their HRV data, one in five, the other 80% are looking at a number every day or every week or whenever their watch surfaces and not changing anything about how they train in response to what they see. There are several ways to interpret this and the study design cannot fully resolve which is most accurate. One possibility is a knowledge gap. Runners are collecting HRV data but do not know what to do with it, how to interpret their personal trends, what threshold changes should prompt a training modification, or what modifications would be physiologically appropriate. Another possibility is a trust gap. Runners have seen enough day to day HRV variability that they have stopped believing the metric is reliable enough to act on. A third possibility is that some runners are integrating HRV into a broader set of perceived exertion, sleep quality, mood, muscle soreness without formally attributing their training adjustments to the HRV number itself. The methodological constraints are worth noting. This is a survey study. While self report data carries the well known limitations of recall bias, social desirability effects, and the gap between what people report doing and what they actually do. 210 respondents from a single survey channel may not represent the full diversity of habitual runners across different geographies, income brackets, age groups and competitive levels. The survey was 13 items necessarily limited in what it could explore about the nature and context of HRV informed training decisions, but the contribution is real and practically important for the HRV technology industry, for coaching platforms, and for sports scientists developing training guidance. The adoption problem has largely been solved. Nearly half of serious habitual runners are already tracking hrv. The remaining challenge is utilization, helping those runners understand what the data means, how to interpret trends rather than individual readings, and how to translate that interpretation into specific evidence based training decisions. That is a different problem from adoption and it requires different solutions. Better in APP guidance, better integration with training platforms, better educational content, data supporting personalized HRV guided training are accumulating. The question is whether the interface between the data and the athlete is is keeping pace. We have been traveling across this episode through laboratories, emergency departments, sports medicine clinics, and running trails. Now let's move into the pain clinic and specifically into a question that sits at the intersection of sensory neuroscience, affective psychology, and autonomic physiology. Chronic pain is one of the most prevalent and disabling conditions in the world. It affects hundreds of millions of people across all age groups, geographies, and socioeconomic strata. And despite decades of research it its management remains stubbornly difficult. Pharmacological approaches carry significant risks and limitations. Non pharmacological adjuncts are urgently needed ones that are safe, accessible, and capable of addressing not just the sensory dimension of chronic pain, but the psychological and autonomic dimensions that amplify and sustain it. This study was published in the Journal of Pain Research is titled Effects of Music Intervention on Pain, Mood, Sleep, and Heart Rate Variability in Patients with Chronic Pain, A randomized controlled Trial. The authors are Bo Wang, Fan Yu, Yan Taoma Hui, Yingzhou, Wei Wu and Yongjunjiang, Bo Wang and Fan Yu, as well as Wei Wu and Yongjunjiang. The study enrolled 79 participants with chronic pain, a clinically meaningful and practically important population, not healthy volunteers. Chronic pain, as the authors note, is the most prevalent form of pain experienced by patients and it carries a well documented constellation of secondary depression, anxiety, sleep disturbance, and the autonomic dysregulation that both contributes to and is worsened by all of the above. The intervention was receptive music listening. Participants in the experimental group listened to music as a guided structured therapeutic activity rather than casual background sound. Combined with health education. The control group received only health education. The primary outcome was pain severity measured via the Simplified McGill Pain Questionnaire. Secondary outcomes included depression assessed with The Patient Health Questionnaire 9, anxiety measured via the Generalized Anxiety Disorder 7th scale, sleep quality through the Pittsburgh Sleep Quality Index and heart rate variability. Assessments for the experimental group were conducted at three time baseline immediately after the intervention and two weeks post intervention, which is an important design feature. The two week follow up allows the team to distinguish transient effects from those that persist after the active intervention period ends. Now here's where the findings require careful and layered reading because the story the data tells is more nuanced than a simple music therapy works headline and more interesting for it. On the primary pain outcome, you were at the total simplified McGill Payne questionnaire score. There was no statistically significant difference between the experimental and control groups after intervention. Both groups showed improvement over time, but the music therapy group did not significantly outperform health education alone on the composite pain measure. That is a null result on the headline outcome and it deserves to be stated clearly. However, when the researchers examined the present pain intensity sub score, a specific component of the questionnaire that captures the immediate in the moment intensity of the pain, the experimental group showed significantly lower scores than the control group. So within the broader pain picture, music therapy appears to have moved a specific dimension of pain severity, the current experiential intensity, even when it did not shift the broader composite score. That is a meaningful distinction. It suggests that music listening may act preferentially on the real time effective dimension of pain perception rather than on the broader cognitive evaluative pain appraisal captured by the full questionnaire. The depression finding is clinically important. PHQ9 scores improved significantly more in the experimental group compared to the control group. [00:40:28] This matters because depression is not incidental to chronic pain. It is one of its most disabling complications, maintaining a bidirectional relationship in which pain worsens depression and depression amplifies pain. An intervention that addresses both simultaneously, even partially, has compounded clinical value. And then there is the HRV finding. And this is where the study speaks most directly to our community's core interest. The LF HF ratio of hrv, a marker of autonomic balance, showed significantly greater improvement in the music therapy group than in the control group. In practical terms, the music intervention shifted the autonomic balance in a favorable direction as reflected in a reduction in the LF HF ratio, indicating a shift away from sympathetic dominance toward a more parasympathetically balanced state. This finding is physiologically coherent. Chronic pain is associated with sustained sympathetic overdrive. The autonomic nervous system, under the continuous burden of pain signaling, tilts away from the rest and digest parasympathetic state toward the fight or flight sympathetic state. If music listening can partially counteract that tilt, reducing the LF HF ratio, restoring some degree of sympathovagal balance, then it is not merely providing a pleasant distraction from pain it is intervening at the level of the autonomic nervous system, modulating the regulatory environment in which pain is processed and amplified. As we mentioned in previous episodes, the LF HF ratio is not fully validated as a metric of sympathetic activation. It doesn't make the result invalid, but keep this controversy around this metric in mind. [00:41:49] On anxiety and sleep, however, no significant intergroup differences were found. This is worth naming as a genuine limitation of the current evidence, not a footnote. If sleep and anxiety are part of the chronic pain burden, and they clearly are, then an intervention that leaves these dimensions unaffected has addressed only part of the problem. Whether longer intervention periods, different music selection strategies, or combined protocols could extend the benefits into the sleep and anxiety domains is an open, practically important question. The methodological constraints deserve precision. 79 participants are a modest sample, and the chronic pain category is heterogeneous back pain, neuropathic pain, musculoskeletal pain, visceral pain with different underlying mechanisms and different autonomic profiles. The study does not fully characterize or stratify by pain type, which limits our ability to know which chronic pain populations are most likely to benefit. The music protocol, receptive listening, was standardized within the study, but music selection, listening duration, and the listener's personal relationship to the music are difficult to fully control and may significantly influence both psychological and autonomic responses. An LF HF ratio, as we have noted in previous episodes, carries interpretive complexity. Its use as a sympathovagal index is not without controversy in the contemporary HRV task force literature. What this study contributes despite those constraints is a rigorous randomized controlled trial design applied to a question that the complementary medicine literature too often addresses. Without adequate experimental control, the concept of music therapy for pain is not new. A clean, randomized, controlled evaluation of its effects on autonomic function in a chronic pain population with HRV as an objective physiological outcome is far less common for pain management clinicians. The autonomic dimension of music therapy's benefit is now an evidence based conversation, not merely a theoretical one. For researchers, the selective effect on present pain intensity and LF HF ratio without corresponding effects on sleep and anxiety provides a mechanistically specific hypothesis about where and how music intervention acts in the complex pain autonomic effect system. We close today's episode in territory that is by any measure under explored. The autonomic nervous system has been studied extensively in the context of pain, cardiac disease, mental health conditions, and athletic performance, primarily in adults. Its role in pediatric populations and specifically in children navigating the complex and often invisible suffering of functional gastrointestinal conditions has received far less attention and within that already underattended domain, the relationship between autonomic function, sleep disturbance, and abdominal pain in children and the degree to which that relationship differs between girls and boys is a question that most of the HRV literature has not even thought to ask. This study was published in Neurogastroenterology and Motility and is titled Relationship between Heart Rate Variability and Sleep among Girls and Boys with Abdominal Pain Related Disorders of Gut Brain Interaction. The authors are Kendra J. Camp, Robert L. Burr, Camden E. Mathern, Emily Simons, Tasha Murphy, Margaret M. Heitkemper, Rhona L. Levy, Robert J. Schulman, and Miranda AL Van Tilberg. Let's establish the clinical context. Abdominal Pain Related Disorders of Gut Brain Interaction, abbreviated apdgbi, is the contemporary diagnostic framework for what was previously called functional abdominal pain or irritable bowel syndrome in children. These are conditions in which recurring, often debilitating abdominal pain occurs in the absence of a structural or biochemical abnormality detectable by standard investigations. They are not imaginary they reflect dysregulation in the bi directional communication between the brain and the gastrointestinal tract, a system in which the autonomic nervous system is a central participant. Children with APDGBI frequently report sleep disturbances and this is not incidental. Poor sleep and abdominal pain form a bidirectional self reinforcing cycle. Pain disrupts sleep, disturbed sleep amplifies pain sensitivity, and the autonomic nervous system is implicated in both directions of that loop. This study used baseline data from a randomized controlled trial enrolling 156 children aged 7 to 12 years with APDGBI. HRV was measured after dinner using a polar monitoring device, a valid, well characterized instrument in pediatric autonomic research. Sleep disturbances were assessed using the Children's Sleep Habits Questionnaire, a validated parent report instrument covering multiple dimensions of sleep quality, timing, and behavior. The analytical approach examined associations between HRV indices and sleep characteristics using partial correlations controlling for age and critically stratified by sex, that sex stratification turns out to be one of the most important decisions in the entire design. Here's what the analysis found and the sex differentiated pattern is the headline. Among girls, higher parasympathetic activity, specifically higher LENRMSSD and higher LEN PNN 50 was associated with longer sleep onset delay. In plain terms, girls with greater vagal tone took longer to fall asleep separately. A lower heart rate in girls was correlated with increased sleep anxiety. These findings are not immediately intuitive and they challenge a simple model in which higher parasympathetic tone is uniformly beneficial. In this pediatric population with functional gut brain conditions, elevated vagal activity may reflect something other than calm relaxation, perhaps hypervigilance in the gut brain axis or interoceptive hyper awareness that paradoxically prolongs the process of settling in asleep rather than facilitating it. Among boys, the pattern was different. Lower autonomic balance specifically lower LNLF HF ratio was associated with increased daytime sleepiness. Lower LF HF reflecting relative parasympathetic dominance or reduced sympathetic contribution to the autonomic balance, correlated with drowsiness during the day, suggesting that disrupted nocturnal autonomic regulation was expressed as impaired daytime alertness in boys rather than in the bedtime. Specific difficulties seen in girls and then across both sexes. Lower low frequency HRV was associated with greater sleep disorder breathing. Post hoc analysis confirmed that children with sleep disordered breathing had significantly lower HRV across multiple indices compared to those without. This finding, while less mechanistically novel, is clinically important in this population because sleep disordered breathing in children with AP DGBI is not always systematically evaluated and reduced HRV may serve as a flag prompting its investigation. The sex specific findings deserve more than a passing acknowledgment. The autonomic nervous system does not operate identically across sexes, even in children. Hormonal environment, neurological development trajectories, and sex differentiated patterns of autonomic maturation all contribute to these differences. Research designs that average across sex rather than stratify within it may mask clinically important and biologically real patterns. In a population of children with gut brain dysregulation and sleep disruption, the specific autonomic signature differs between girls and boys and that difference may have implications for how clinicians approach management, which interventions are prioritized and and how family education is framed. The methodological constraints are important to name carefully. This is a cross sectional analysis of baseline data. Causal direction cannot be established. The HRV measurement was taken at a single post dinner time point, which introduces circadian timing as a potential confound. Post dinner autonomic state is influenced by meal size, food composition, and digestive activity in ways that may interact with the APDGBI pathophysiology. The Children's Sleep Habits Questionnaire is a parent report measurement. Children's own perceptions of their sleep experience may differ. The age range of 7 to 12 is biologically diverse. A 7 year old and a 12 year old occupy quite different developmental and prepubertal or pubertal positions, and the study does not fully account for this heterogeneity. Despite those constraints, this study contributes a framework and a starting set of findings that the pediatric autonomic gastroenterology and sleep medicine communities genuinely need. Children with functional gastrointestinal conditions are among the most underserved populations in terms of mechanistic understanding, and the autonomic dimension of their sleep disturbance is a tractable, measurable, and potentially modifiable target. For pediatric gastroenterologists, HRV assessment in children with APDGBI who report sleep difficulties may provide a biological context that the symptom questionnaire alone cannot. For researchers designing interventions in this population, sex stratification is not optional it is essential for understanding who is responding to what and through which autonomic pathway. Nine studies, nine distinct domains of inquiry and yet, as we step back and look at what this week's research is collectively doing, a set of converging themes emerges with real clarity. The first theme is mechanistic precision. The HRV field is maturing beyond simple correlations between a metric and an outcome toward a more sophisticated understanding of mechanism and specificity. Minjoes, Jian, Pelissier, and Hod showed us that the psychological benefits of HRV biofeedback exceed placebo, but that HRV itself may not be the primary mechanism. Mao, Okutomi, and Umeno showed that during cognitive engagement, meaningful signals may lie in chaos and complexity indices that standard HRV metrics cannot detect. Wang, Yu, Ma, Zhao, Wu, and Jing showed us that music therapy selectively modulates the LF HF ratio in chronic pain patients not through placebo but through what appears to be a genuine autonomic intervention. All three findings invite the same productive question Are we measuring the right thing in the right way for the right purpose? The second theme is the power and the limits of trajectory. Markovich, Petrovich, Babic, Bojic, and Milovanovic showed US in a 230 patient post infarct cohort that the direction of change in HRV over three weeks carries prognostic information that a single point measurement cannot provide. And Dellingbrandt, Jacobs, Meyer, Koenen and Reinsberger showed us that clinical symptom resolution after concussion does not guarantee autonomic recovery. The nocturnal RMSSD was still suppressed after athletes had been cleared to return to sport. Both findings argue for a longitudinal rather than cross sectional approach. Where is the autonomic system going? Not just where it is today. [00:50:46] The third theme is the challenge of clinical translation. Seely, Barnaby, Hudek, Harry, Scales, Fernando, Brehout and Perry gave us a clear eyed look at what it actually takes to bring an HRV based clinical tool into a real emergency department. The feasibility, the perceived value, the barriers, the iterative design process. And Carnes and Mahoney showed us that adoption of HRV monitoring has outpaced utilization among runners. Nearly half track it, but only one in five does anything differently because of it. In both cases, the technology is not the limiting factor. Understanding, trust and accessible interpretation are. The fourth theme is specificity of population, of sex, of condition. Milovanovic, Markovich, Petrovich, Korogi, and Bojic deepened our understanding of what pointerre plot geometry adds to conventional HRV in a clinical population with suspected autonomic dysfunction. Camp, Burr, Mathern, Simons, Murphy, Heitkemper, Levy, Shulman, and Van Tilberg showed us that the autonomic correlates of sleep disturbance in children with gut brain pain disorders differ meaningfully between girls and boys. And Wong and colleagues showed us that within the broad category of chronic pain, music therapy's autonomic effect may be specific to the sympathovagal balance dimension rather than to sleep or anxiety. One size fits all HRV interpretation across age groups, across sexes, across clinical conditions is increasingly untenable as the literature grows more granular for individuals listening to this episode. Wherever you sit in relationship to the HRV metric, tracking it daily on a wearable, monitoring it as part of athletic training, encountering it in a clinical setting. The consistent message from this week's research is that the number is a starting point, not an answer. The direction matters, the timing matters, the population context matters, and the dimension of the signal you are measuring. Linear or nonlinear, short term or long term, daytime or nocturnal may be capturing something quite different from what you assume. [00:52:34] For clinicians, four of this week's studies point directly toward clinical application. Post infarct HRV trajectory warrants attention as a low cost prognostic tool at the bedside. The combined use of HRV and laboratory values in emergency presentations of infection is feasible and perceived as clinically valuable. Music therapy demonstrates an objective autonomic benefit in chronic pain patients that justifies its consideration as an adjunctive intervention and in children with functional abdominal pain disorders. The autonomic nervous system appears to be a meaningful contributor to sleep disruption in ways that differ between girls and boys and that are measurable with existing technology. For researchers, the calls to action from this week's studies are crisp. We need longitudinal designs to replace the cross sectional snapshots that have dominated the field. We need sex stratified analyses as a methodological standard, not an afterthought. We need larger samples in multi site replication, particularly in the concussion, hrv, pediatric gut, brain and Poincare plot domains. And we need methodological creativity around what dimension of the HRV signal to analyze and in what window, under what conditions, in what population, for what clinical or research purpose. Because the signal is richer than our current standard metrics reveal. The heart does not simply beat, it communicates with the brain, the gut, the environment, and our history of injury, stress and recovery. Heart rate variability is our most accessible window into that conversation. The research presented this week extends that window, deepens what we see through it, and challenges us to look more carefully at what we thought we already understood. Thank you as always, for joining us. Links to all nine studies discussed today are in the show Notes until next week, keep tracking, keep breathing, and stay curious.